ID

36545

Description

A Randomized, Double-blind, Placebo-controlled Study to Assess Efficacy of Tocilizumab+Non-biological DMARD in Reducing Synovitis as Measured by MRI at 12 Weeks After Initiation of Treatment in Patients With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Non-biological DMARDs; ODM derived from: https://clinicaltrials.gov/show/NCT01034397

Link

https://clinicaltrials.gov/show/NCT01034397

Keywords

  1. 1/19/19 1/19/19 -
  2. 5/21/19 5/21/19 -
Copyright Holder

Hoffmann-La Roche

Uploaded on

May 21, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Tocilizumab and non-biological DMARD in Rheumatoid Arthritis NCT01034397

Eligibility Criteria

  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >/=18 years of age
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
moderate to severe rheumatoid arthritis of >/=6 months duration
Description

Rheumatoid Arthritis Severity and Duration

Data type

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0449238
UMLS CUI [2,1]
C0003873
UMLS CUI [2,2]
C1319166
synovitis (swollen and tender joint) in the wrist of the dominant hand
Description

Synovitis in wrist of dominant hand

Data type

boolean

Alias
UMLS CUI [1,1]
C0039103
UMLS CUI [1,2]
C1322271
UMLS CUI [1,3]
C0449722
non-biologic DMARDs at stable dose for >/=12 weeks prior to baseline
Description

Non-biologic DMARDs stable dose

Data type

boolean

Alias
UMLS CUI [1,1]
C4054347
UMLS CUI [1,2]
C0205360
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C0332185
oral corticosteroids at stable dose for at least 25 out of 28 days prior to baseline
Description

Oral Corticosteroids stable dose

Data type

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [1,4]
C0442027
UMLS CUI [1,5]
C0332185
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
rheumatic autoimmune disease other than RA
Description

Rheumatic disease other than RA

Data type

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0035435
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C0003873
history of or current inflammatory joint disease other than RA
Description

History of or current inflammatory joint disease other than RA

Data type

boolean

Alias
UMLS CUI [1,1]
C0683381
UMLS CUI [1,2]
C1705847
UMLS CUI [1,3]
C0003873
UMLS CUI [1,4]
C0262926
UMLS CUI [2,1]
C0683381
UMLS CUI [2,2]
C1705847
UMLS CUI [2,3]
C0003873
UMLS CUI [2,4]
C0521116
functional class IV (ACR classification)
Description

ACR

Data type

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0598463
UMLS CUI [1,3]
C0456387
intraarticular or parenteral corticosteroids within 6 weeks prior to baseline
Description

Intraarticular or Parenteral Corticosteroids

Data type

boolean

Alias
UMLS CUI [1,1]
C4039704
UMLS CUI [1,2]
C0332185
UMLS CUI [2,1]
C2064783
UMLS CUI [2,2]
C0332185
previous treatment with a biologic agent for RA
Description

Previous biologic agent

Data type

boolean

Alias
UMLS CUI [1,1]
C1531518
UMLS CUI [1,2]
C0003873

Similar models

Eligibility Criteria

  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
adult patients, >/=18 years of age
boolean
C0001779 (UMLS CUI [1])
Rheumatoid Arthritis Severity and Duration
Item
moderate to severe rheumatoid arthritis of >/=6 months duration
boolean
C0003873 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C1319166 (UMLS CUI [2,2])
Synovitis in wrist of dominant hand
Item
synovitis (swollen and tender joint) in the wrist of the dominant hand
boolean
C0039103 (UMLS CUI [1,1])
C1322271 (UMLS CUI [1,2])
C0449722 (UMLS CUI [1,3])
Non-biologic DMARDs stable dose
Item
non-biologic DMARDs at stable dose for >/=12 weeks prior to baseline
boolean
C4054347 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,4])
Oral Corticosteroids stable dose
Item
oral corticosteroids at stable dose for at least 25 out of 28 days prior to baseline
boolean
C0001617 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0442027 (UMLS CUI [1,4])
C0332185 (UMLS CUI [1,5])
Item Group
C0680251 (UMLS CUI)
Rheumatic disease other than RA
Item
rheumatic autoimmune disease other than RA
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0003873 (UMLS CUI [1,4])
History of or current inflammatory joint disease other than RA
Item
history of or current inflammatory joint disease other than RA
boolean
C0683381 (UMLS CUI [1,1])
C1705847 (UMLS CUI [1,2])
C0003873 (UMLS CUI [1,3])
C0262926 (UMLS CUI [1,4])
C0683381 (UMLS CUI [2,1])
C1705847 (UMLS CUI [2,2])
C0003873 (UMLS CUI [2,3])
C0521116 (UMLS CUI [2,4])
ACR
Item
functional class IV (ACR classification)
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Intraarticular or Parenteral Corticosteroids
Item
intraarticular or parenteral corticosteroids within 6 weeks prior to baseline
boolean
C4039704 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C2064783 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
Previous biologic agent
Item
previous treatment with a biologic agent for RA
boolean
C1531518 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial